Reliq Health Technologies Inc.

Reliq Health Technologies, formerly Moseda Technologies, is a Vancouver, BC-based healthcare technology company that specializes in developing innovative, secure mobile software solutions for the $20 billion community care market. The company's iUGO health platform is a comprehensive hardware and software solution that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients and families, and reducing the cost of care.

Expert Comments:

Chris Parry, Equity Guru (10/5/17)
"Reliq Health Technologies Inc. has four pilots going with medium to large healthcare providers, with the biggest being the British universal health provider, the National Heath Service (NHS). Pilots are fine. Companies do pilots. The proof of a future has always been, can you move from a pilot to a full program? Well, Reliq has. They've now got 1000 patients into their system from two customers, and expect somewhere between 2000 and 2500 to be added next month. In financial terms, they're bringing in $50k per month ($600k per year) in recurring revenue now. $150k per month ($1.8m per year) if projections play out in October. The plan is to move 40,000+ patients into the system at that rate, which would bring $26 million at full deployment. And that's with just the customers using the system now. If the NHS were to take it on, though admittedly that would be a far longer process to complete, the dollar value would be insane."

Clive Maund, CliveMaund.com (9/22/17)
"Reliq Health Technologies Inc. is an exciting looking medical stock that is just starting to break out of a 4+year long base pattern on massive volume. The company is a pioneer in technologies that allow hospital patients to return home sooner, thus cutting costs and freeing up space in hospital rooms and wards, which involve technologies that permit patients to be monitored remotely at home by doctors and nurses."

Michael Berger, TalkMarkets (9/6/17)
"Reliq Health Technologies Inc. reported a major milestone after its remote patient monitoring and telemedicine solution with Paz Home Health went live. . .a few weeks later, the healthcare technology company announced another milestone after going live with its remote patient monitoring, care coordination and telemedicine platform with Rio Grande Valley Health Alliance. . .August was a banner month for Reliq and these developments have the firm positioned for incremental growth. The company has contracts in place with a 12,000-patient home care agency and a 36,000 patient ACO that are expected to generate $17-23M in recurring annual revenue in 2018."

Experts Following This Company

Bruce Campbell, Founder and Portfolio Manager – Stonecastle Investment Management
Clive Maund – gold, silver & oil shares
Chris Parry – Equity Guru

The information provided above is from analysts, newsletters, the company and other contributors.

Reliq Health Technologies Inc. is a former billboard advertiser of Streetwise Reports. The company's advertising fees paid for Streetwise Reports to create this "Investor Summary Page," to which links were placed on Streetwise Reports' websites and newsletters. Streetwise Reports did not accept stock for the payment of fees. See disclaimer for more details.

The company description, investing highlights and catalyst calendar on this page were prepared by the company. The Expert Comments and Experts Following This Company sections of this page are compiled by Streetwise Reports. There may be other information about the company that is not placed on this page. Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on this page.

The Expert Opinions above are excerpted from third-party sources not affiliated with or controlled by Streetwise Reports. The statements or opinions expressed in the Expert Opinions above are those of the authors indicated, and Streetwise Reports has not verified the accuracy of material excerpted here.

Streetwise Reports does not provide investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security.Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

Readers should conduct their own research for all information publicly available concerning the company.